Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Human Genetics|October 18, 2002
Associations between gene expressions in breast cancer and patient survivalT-K Jenssen, W P Kuo, T Stokke, et al.Mutation Research|January 1, 1991
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionE Hovig, B Smith-Sørensen, A Brøgger, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2002
CA 125: the end of the beginningE Hovig, P D Rye, D J Warren, et al.Cancer Genetics and Cytogenetics|December 1, 1992
A TP53 mutation detected in cells established from an osteosarcoma, but not in the retinoblastoma of a patient with bilateral retinoblastoma and multiple primary osteosarcomasE Hovig, A Andreassen, B M Fangan, et al.Mutation Research|September 1, 1992
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)B Smith-Sørensen, E Hovig, B Andersson, et al.American Journal of Human Genetics|August 12, 1999
Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerA Dørum, K Heimdal, E Hovig, et al.Pharmacogenetics|December 1, 1992
Detection of DNA variation in cancerE Hovig, B Smith-Sørensen, A G Uitterlinden, et al.Cancer Genetics and Cytogenetics|February 1, 1987
Chromosome 13 instability and esterase D expression in an osteosarcoma cell lineE Hovig, J O Winberg, O Fodstad, et al.Human Genetics|March 10, 1999
Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53A I Wacey, D N Cooper, D Liney, et al.Disease Markers|December 14, 1999
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutationsA Borg, A Dørum, K Heimdal, et al.Pageof 8